Find out what makes us unique and the work we do with our revolutionary CryptoMapTM platform.
All the latest company news, press releases and updates from Epitopea.
Epitopea is a fast-growing trans-Atlantic biotech company formed to exploit an exciting opportunity to deliver durable treatment options to cancer patients. Our proprietary CryptoMapTM platform has uncovered numerous tumor specific antigen targets, which we are encoding into CryptiVaxTM products for cancer indications with very high unmet medical need.
Our teams of ambitious dynamic scientists are based in Cambridge (UK) and Montreal (Canada) and are inspired by the opportunity to design and build the safest and most efficacious mRNA-based immunotherapies, building on a culture of inquisitiveness, camaraderie and urgency as we seek to deliver these game-changing therapies to cancer patients.
Epitopea offers competitive salaries and benefits packages along with a fast-paced environment characterised by an ethic of strong teamwork.
Epitopea subscribes to the principle of equal access to employment and encourages diversity and integration. We consider all applications, regardless of the candidate's nationality, religion, gender, sexual orientation, gender identity, age or disability, and we respect all legally protected characteristics.
Please note that we will only communicate with successful candidates.
| Job Title: | Immunologist |
|---|---|
| Location: | Cambridge, UK |
| Working Conditions: | Full-time position |
| Full Description: | Experienced and passionate Immunologists sought for Translational Development of Therapeutic Cancer Vaccines Epitopea is an immuno-oncology company with lab operations in Cambridge, UK. Our founding scientists at the Université de Montreal have identified new sets of potentially shared tumour specific antigens (TSAs) opening the way to a new generation of cancer therapeutics. Epitopea is funding discovery of further TSAs, prioritizing the most translatable and aims to exploit them for cancer therapy via therapeutic vaccines and other modalities. Epitopea is backed by a world-class syndicate of life-science investors and its approach is now validated by our signing of a collaboration agreement with a leading immuno-oncology pharma company. Responsibilities We are looking to build a translation biology team to support the transition of our therapeutic cancer vaccines into clinical development. In the short term these roles will involves validating antigen immunogenicity, but in 2026 we will be moving into the clinic and the primary focus will become assessing vaccine-induced immune responses to the cancer antigens included in our off-the-shelf mRNA vaccines. We are looking for skilled people experienced at working with human T cells and screening assays for these lab-based on-site positions at the Babraham Research Campus. The ideal candidates will be team players with exceptional attention to detail, good time management skills and relevant immunology experience. Experience working in regulated environments and with clinical samples is preferred. Successful candidates would join a collaborative and ambitious team with a synergistic range of skills and backgrounds. Further information about our founding research can be found on our website https://www.epitopea.com/ Qualifications Basic qualification and skills
Preferred qualification and skills
Please apply by sending a CV and covering email explaining why you are interested and suitable for these positions to hr@epitopea.com |
| Apply: | Apply Today |
